The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...

So, Regeneron's revenue rose 1.9% from $3.68 billion in Q2 2025 to $3.75 billion, beating consensus estimate by $160 million ...

In a bid to deepen its manufacturing foothold in the U.S., Regeneron Pharmaceuticals in April pledged production and infrastructure investments surpassing $7 billion across North Carolina and its ...

After months of back-and-and forth with the FDA and a third-party manufacturer, Regeneron has secured two long-awaited approvals for Eylea HD, gaining a new indication and a more flexible dosing ...

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...

SARATOGA SPRINGS, N.Y. — Gov. Kathy Hochul recently announced that Regeneron Pharmaceuticals, a global leader in biotechnology founded in New York State, will create 1,000 new jobs as part of a $2 ...

Regeneron Pharmaceuticals received approval from the U.S. Food and Drug Administration for its eye treatment Eylea HD. The approval is for Eylea to treat macular edema following retinal vein occlusion ...

Thanks so much, everyone. It's funny. I had -- I was talking to an investor, and he -- it was his first time in London. He goes, it's not that crowded. And I think it's going to be okay, and I told ...

PALO ALTO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, ...

When Carmen Thomas was growing up in Boston, her mom told her that her absent dad’s name was Joe Brown. So when she sent a saliva sample to 23andMe in her 20s and got a match with a Brown, she was ...

(WKBN) – A federal judge has given the green light for the sale of genetics and biotech company 23andMe. 23andMe Holding Co. will be sold to TTAM Research Institute, a genetics-led healthcare company ...